Leeanna Beech, PA
Physician Assistant · Memphis, TNNPI 1891358016
Payments from drug & device makers
Across 90 payments — averaging $25.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$734
- Amgen$301
- E.r. Squibb & Sons, L.L.C.$251
- Sun Pharmaceutical Industries Inc.$198
- Smith+Nephew$181
- Galderma Laboratories, L.p.$133
- plus $481 from 10 others
What the payments were for
- Food & beverage$2,18196%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $734 |
| Amgen | 13 | $301 |
| E.r. Squibb & Sons, L.L.C. | 10 | $251 |
| Sun Pharmaceutical Industries Inc. | 7 | $198 |
| Smith+Nephew | 11 | $181 |
| Galderma Laboratories, L.p. | 3 | $133 |
| UCB, Inc. | 3 | $92 |
| Pfizer | 5 | $89 |
| Johnson & Johnson | 3 | $62 |
| Novartis | 3 | $61 |
| Verrica Pharmaceuticals Inc. | 2 | $46 |
| Boston Scientific | 1 | $31 |
| Boehringer Ingelheim | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $27 |
| LNHC, Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
How this compares
$2,280 in reported general payments places this provider in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpzeluraRuxolitinib Phosphate | 28 | $70,823 |
| Dupixent PenDupilumab | 17 | $60,115 |
| Tacrolimus | 54 | $12,929 |
| Tretinoin | 63 | $5,422 |
| Clobetasol Propionate | 103 | $4,662 |
| Ivermectin | 12 | $3,963 |
| Ketoconazole | 175 | $3,157 |
| Desonide | 40 | $3,013 |
| Metronidazole | 23 | $1,842 |
| Clindamycin Phosphate | 67 | $1,714 |
| Gentamicin Sulfate | 36 | $1,632 |
| Hydrocortisone | 45 | $1,292 |
| Fluorouracil | 17 | $1,237 |
| Fluocinonide | 15 | $852 |
| Ciclopirox | 30 | $794 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Memphis
- Whitney GatewoodMemphis$104K
- Emily KunstmanMemphis$13K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.